Laboratory Centrifuge Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Laboratory Centrifuge Market is Segmented by Product Type (Equipment [Microcentrifuges, Ultracentrifuges, and More], Accessories [Tubes & Bottles, and More]), by Model Type (Benchtop, Floor-Standing), by Application (Microbiology, Cellomics, and More), by End-User (Hospitals & Diagnostic Labs, and More), by Automation Level (Manual / Conventional, and More), by Geography (North America, Europe, Asia-Pacific, and More).

Global Laboratory Centrifuge Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Global Laboratory Centrifuge Market with other markets in Healthcare Industry

Global Laboratory Centrifuge Market Analysis by Mordor Intelligence

The laboratory centrifuge market size stands at USD 1.71 billion in 2025 and is projected to reach USD 2.27 billion by 2030, advancing at a 5.81% CAGR. Vigorous demand from cell and gene therapy manufacturing, recovery in bioprocessing activity, and the push to automate diagnostic workflows anchor this expansion. Players enlarge capacity for viral-vector purification and integrate robotics to reduce manual touchpoints, while sustainability mandates spur adoption of energy-efficient refrigerated systems. North America holds the largest revenue base, yet Asia-Pacific logs the quickest gains as China and India channel public policy and capital into domestic medical-device production. These factors together reinforce the strategic relevance of the laboratory centrifuge market across precision medicine, academic research, and decentralized testing networks.

Key Report Takeaways

  • By product type, equipment commanded 76.47% revenue share of the laboratory centrifuge market in 2024; accessories are forecast to post a 7.12% CAGR through 2030.
  • By model type, benchtop systems led with 61.86% share in 2024, whereas floor-standing units are set to grow at 6.57% CAGR to 2030.
  • By intended use, clinical applications accounted for 52.79% of the laboratory centrifuge market share in 2024, while pre-clinical research is projected to expand at a 6.36% CAGR.
  • By application, diagnostics held 37.34% of revenue in 2024; cellomics is expected to record the highest 7.37% CAGR through 2030.
  • By end-user, hospitals and diagnostic labs captured 47.32% of 2024 revenue, but biotech and pharma companies are poised for a 6.88% CAGR.
  • By geography, North America led with 36.48% share in 2024, while Asia-Pacific is forecast to accelerate at a 7.76% CAGR.

Segment Analysis

By Product Type: Equipment Dominance Drives Accessories Innovation

Equipment represented 76.47% of 2024 revenue, confirming users’ primary focus on platform procurement within the laboratory centrifuge market. Ultracentrifuges reach speeds above 100,000 rpm, supporting protein and virus separation for biologics research. Microcentrifuges remain staples of routine assays, while multipurpose units cater to institutions needing rotor flexibility. The laboratory centrifuge market size for accessories is smaller but displays faster momentum as laboratories replace tubes, bottles, and rotor seals after repeated sterilization cycles. Carbon-fiber rotors, lighter yet corrosion-resistant, now enter service contracts that guarantee load balancing and fatigue inspection.  

The accessories segment grows at 7.12% CAGR because consumables are replaced more frequently than hardware. Fixed-angle and swinging-bucket formats account for most aftermarket demand, backed by vendor programs that bundle rotor upgrades with calibration services. As high-throughput screens expand, laboratories secure bulk lots of single-use tubes to avoid cross-contamination. Manufacturers thus bank on recurring sales that complement initial hardware margins, reinforcing the resilience of the laboratory centrifuge market.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Model Type: Benchtop Systems Balance Performance and Space Efficiency

Benchtop units held 61.86% revenue in 2024, favored for daily diagnostic and academic protocols that handle volumes under 500 mL. Their compact footprint aligns with space-limited benches, and recent firmware updates add touch-screen controls plus QR-code maintenance logs. In contrast, floor-standing models realise a 6.57% CAGR by accommodating bags and bottles needed for upstream bioprocess harvests. Programmable ramps and vibration dampers meet GMP validation rules, which lifts their appeal for contract manufacturers.  

The laboratory centrifuge market benefits as institutions deploy mixed fleets: benchtops for stat tests, floor units for batch purification. Integration with robotic arms enables unmanned loading, turning traditional floor systems into automated work cells. Vendors now offer hybrid service plans that remotely track rotor cycles across both model lines, minimising downtime while retaining operator familiarity.

By Intended Use: Clinical Applications Drive Volume While Research Accelerates Innovation

Clinical laboratories generated 52.79% of revenue in 2024, highlighting centrifugation’s irreplaceable role in blood‐chemistry, coagulation, and urinalysis workflows. Hospitals value resilient designs, redundant safety locks, and global service coverage. Conversely, the pre-clinical research segment’s 6.36% CAGR shows how biotech start-ups and academia seek higher g-force ranges and programmable gradients to explore novel biomarkers.  

These divergent needs push suppliers to maintain dual product lines. Research models add data export and temperature mapping, while clinical versions emphasise cycle repeatability under strict accreditation. Both segments underpin the broader laboratory centrifuge market by committing to recurring rotor inspection contracts that protect accreditation status.

By Application: Diagnostics Leadership Faces Cellomics Challenge

Diagnostics held 37.34% of 2024 revenue, cementing its status as the laboratory centrifuge market cornerstone. Typical protocols include plasma separation for metabolic panels and pathogen pelleting for PCR. Cellomics now grows at 7.37% CAGR because single-cell analytics and CAR-T workflow steps need gentle yet precise spin profiles.  

Proteomics and genomics groups modernise ultracentrifuges to enrich organelles and nucleic acids before mass spectrometry or sequencing. Meanwhile, microbiology labs depend on sealed-bucket designs to avoid aerosol exposure. Each application tier extends the serviceable base for calibration and rotor balancing, ensuring consistent expansion of the laboratory centrifuge market.

By End-user: Hospitals Lead While Biotech Accelerates

Hospitals and diagnostic labs owned 47.32% of revenue in 2024, reflecting frequent sample turnover and compliance-driven purchasing cycles. They value warranties that cover weekend callouts and guaranteed spare-part stocks. Biotech and pharma companies grow 6.88% CAGR as gene-therapy pipelines scale, demanding single-use, closed-system centrifuges.  

Academic consortia invest in shared core facilities, enabling smaller labs to access ultracentrifugation without full ownership, which broadens the reach of the laboratory centrifuge market. Contract research organisations purchase robotic-ready models to speed client screening campaigns, creating a lively secondary rental channel for midlife units.

Laboratory Centrifuge Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Automation Level: Manual Systems Persist Despite Automation Momentum

Manual and conventional designs constituted 40.19% of 2024 revenue as many clinics still trust hand-loaded spinning for CBC routines. These devices offer intuitive knobs, minimal sensors, and low maintenance costs that suit budget-restricted sites. Fully automated systems, however, rise at 7.26% CAGR as robotics address staffing shortages and reproducibility targets.  

ABB and Mettler-Toledo integrate pick-and-place arms that feed racks directly into refrigerated chambers. Vendors also link centrifuge cycle data to laboratory information management systems, supporting electronic audit trails vital for GMP. The layering of AI-based predictive maintenance nudges the laboratory centrifuge market toward service-oriented revenue models.

Geography Analysis

North America retained 36.48% of 2024 revenue, anchored by the United States’ dense cluster of pharmaceutical headquarters, National Institutes of Health grants, and a robust contract manufacturing base. Canada complements with public health labs and a growing biologics ecosystem, while Mexico benefits from near-shoring of medical-device assembly. Federal incentives for advanced manufacturing further stimulate orders for GMP-graded centrifuges that feed into local cell-therapy plants. Laboratories also respond to OSHA and CDC safety directives, prompting upgrades to aerosol-tight lids and acoustic dampening, which sustains the laboratory centrifuge market.  

Asia-Pacific posts the fastest 7.76% CAGR. China’s medical-equipment sector reached USD 179 billion in 2024, featuring 138,000 device patents, and state policy favours domestic sourcing.[2]Xinhua, “China Focus: China's medical equipment market reaches 1.27 trillion yuan,” english.news.cnIndia’s National Medical Devices Policy targets USD 50 billion turnover by 2030 and simplifies regulatory pathways, encouraging multinational and local firms to invest in centrifuge assembly lines. Japan, South Korea, and Australia expand clinical-trial networks that demand high-throughput centrifugation, reinforcing the laboratory centrifuge market across the region.  

Europe shows steady growth paced by Germany’s export-oriented device makers, the United Kingdom’s biotech clusters, and France’s hospital modernisation programs. EU directives on eco-design and medical-device regulation encourage adoption of energy-efficient rotors and comprehensive validation records. Sustainability-focused hospitals favor models with 70% lower power draw, aligning procurement with green public-purchasing policies. Collectively, these initiatives keep European demand consistent while opening niches for circular-economy refurbishment services that extend the lifecycle of centrifuge fleets.

Laboratory Centrifuge Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

Market consolidation remains moderate as leading firms pursue scale in bioprocess purification. Thermo Fisher Scientific will acquire Solventum’s Purification & Filtration unit for USD 4.1 billion, expecting USD 125 million operating synergies by year five.[3]Thermo Fisher Scientific, “Thermo Fisher Scientific to Acquire Solventum's Purification and Filtration Business,” ir.thermofisher.com This transaction broadens Thermo Fisher’s one-stop offering from cell harvest to downstream filtration, bolstering its grip on the laboratory centrifuge market. Beckman Coulter, Eppendorf, and Danaher’s Cytiva division defend share via incremental rotor upgrades and cloud-connected service dashboards.  

Automation partnerships reshape competitive positioning. BD teamed with Biosero to mesh flow-cytometer queues with robotic load-unload sequences, demonstrating the appeal of integrated workflows over stand-alone instruments. ABB’s collaboration with Mettler-Toledo on flexible lab cells places industrial robotics inside academic laboratories, pressuring traditional centrifuge makers to supply robot-friendly lids and plate carriers. New entrants concentrate on portable, battery-powered devices for field diagnostics, serving humanitarian missions and veterinary clinics.  

Differentiation hinges on after-sales coverage, compliance documentation, and sustainability features. Vendors promote rotor-exchange programs, traceable maintenance logs, and software updates that unlock new acceleration profiles without hardware swaps. Those capabilities shape purchasing criteria for high-value accounts, ensuring that service depth, not only catalog breadth, steers share within the laboratory centrifuge market.

Global Laboratory Centrifuge Industry Leaders

  1. Thermo Fisher Scientific Inc

  2. Andreas Hettich GmbH & Co. KG

  3. HERMLE Labortechnik GmbH

  4. Danaher Corporation (Beckman Coulter, Inc.)

  5. Qiagen NV

  6. *Disclaimer: Major Players sorted in no particular order
Laboratory Centrifuge Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • April 2025: Beckman Coulter Life Sciences introduced the OptiMATE Gradient Maker, an automated density-gradient instrument that reduces ultracentrifuge preparation time by 75%.
  • April 2025: Thermo Fisher Scientific reported Q1 2025 revenue of USD 10.36 billion and unveiled the Cryofuge refrigerated floor models targeting precision medicine laboratories.
  • February 2025: Thermo Fisher Scientific agreed to purchase Solventum’s Purification & Filtration business for USD 4.1 billion to expand bioproduction capabilities.
  • June 2024: Beckman Coulter launched the Biomek Echo One System, integrating acoustic liquid handling for faster NGS library prep.

Table of Contents for Global Laboratory Centrifuge Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High prevalence of chronic & infectious diseases
    • 4.2.2 Rising R&D spending in biopharma & life sciences
    • 4.2.3 Technological advances in high-throughput & refrigerated systems
    • 4.2.4 Expansion of decentralised/near-patient diagnostic labs
    • 4.2.5 Viral-vector demand for cell & gene therapy manufacturing
    • 4.2.6 Rotor-refurbishment & circular-economy revenue streams
  • 4.3 Market Restraints
    • 4.3.1 High upfront capital cost of advanced systems
    • 4.3.2 Long equipment lifespans slowing replacement sales
    • 4.3.3 Growth of outsourced centrifugation services
    • 4.3.4 Tightening biosafety & noise-emission regulations
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value)

  • 5.1 By Product Type
    • 5.1.1 Equipment
    • 5.1.1.1 Microcentrifuges
    • 5.1.1.2 Ultracentrifuges
    • 5.1.1.3 Multipurpose/General-purpose
    • 5.1.2 Accessories
    • 5.1.2.1 Tubes & Bottles
    • 5.1.2.2 Rotors (fixed-angle, swinging-bucket)
    • 5.1.2.3 Buckets/Plates/Consumables
  • 5.2 By Model Type
    • 5.2.1 Benchtop
    • 5.2.2 Floor-standing
  • 5.3 By Intended Use
    • 5.3.1 Clinical
    • 5.3.2 Pre-clinical/Research
    • 5.3.3 General Purpose
  • 5.4 By Application
    • 5.4.1 Microbiology
    • 5.4.2 Cellomics
    • 5.4.3 Proteomics
    • 5.4.4 Genomics
    • 5.4.5 Diagnostics
  • 5.5 By End-user
    • 5.5.1 Hospitals & Diagnostic Labs
    • 5.5.2 Academic & Research Institutes
    • 5.5.3 Biotech & Pharma Companies
    • 5.5.4 Contract Testing / CROs
  • 5.6 By Automation Level
    • 5.6.1 Manual / Conventional
    • 5.6.2 Semi-automated
    • 5.6.3 Fully-automated / Robotic
  • 5.7 By Geography
    • 5.7.1 North America
    • 5.7.1.1 United States
    • 5.7.1.2 Canada
    • 5.7.1.3 Mexico
    • 5.7.2 Europe
    • 5.7.2.1 Germany
    • 5.7.2.2 United Kingdom
    • 5.7.2.3 France
    • 5.7.2.4 Italy
    • 5.7.2.5 Spain
    • 5.7.2.6 Rest of Europe
    • 5.7.3 Asia-Pacific
    • 5.7.3.1 China
    • 5.7.3.2 Japan
    • 5.7.3.3 India
    • 5.7.3.4 Australia
    • 5.7.3.5 South Korea
    • 5.7.3.6 Rest of Asia-Pacific
    • 5.7.4 Middle East and Africa
    • 5.7.4.1 GCC
    • 5.7.4.2 South Africa
    • 5.7.4.3 Rest of Middle East and Africa
    • 5.7.5 South America
    • 5.7.5.1 Brazil
    • 5.7.5.2 Argentina
    • 5.7.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
    • 6.3.1 Thermo Fisher Scientific Inc.
    • 6.3.2 Danaher Corp. (Beckman Coulter)
    • 6.3.3 Eppendorf AG
    • 6.3.4 Andreas Hettich GmbH & Co. KG
    • 6.3.5 Sigma Laborzentrifugen GmbH
    • 6.3.6 HERMLE Labortechnik GmbH
    • 6.3.7 Kubota Corp.
    • 6.3.8 NuAire Inc.
    • 6.3.9 Sartorius AG
    • 6.3.10 Qiagen NV
    • 6.3.11 Labnics Equipment
    • 6.3.12 Esco Life Sciences
    • 6.3.13 KeraJet / Khera Instruments (Pvt Ltd)
    • 6.3.14 BT Lab Systems
    • 6.3.15 LabMedica (Scheuermann)
    • 6.3.16 Centrisys/CNP LLC
    • 6.3.17 Alfa Laval AB
    • 6.3.18 Becton, Dickinson & Co. (BD)

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Laboratory Centrifuge Market Report Scope

As per the scope of the report, a laboratory centrifuge is a machine that uses centrifugal force for the separation of liquids, fluids, and gas based on density. In research and clinical laboratories, centrifuges are often used for cell, organelle, virus, protein, and nucleic acid purification.

The Laboratory Centrifuge Market is Segmented by Product Type (Equipment (Microcentrifuges, Ultracentrifuges, and Multipurpose Centrifuges) and Accessories (Tubes, Rotors, Centrifuge Buckets, Centrifuge Bottles, and Plates)), Model Type (Floor-Standing Centrifuges and Benchtop Centrifuges), Intended Use (Clinical Centrifuges, Preclinical Centrifuges, and General-Purpose Centrifuges), Application (Microbiology, Cellomics, Proteomics, Diagnostics, Genomics, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type Equipment Microcentrifuges
Ultracentrifuges
Multipurpose/General-purpose
Accessories Tubes & Bottles
Rotors (fixed-angle, swinging-bucket)
Buckets/Plates/Consumables
By Model Type Benchtop
Floor-standing
By Intended Use Clinical
Pre-clinical/Research
General Purpose
By Application Microbiology
Cellomics
Proteomics
Genomics
Diagnostics
By End-user Hospitals & Diagnostic Labs
Academic & Research Institutes
Biotech & Pharma Companies
Contract Testing / CROs
By Automation Level Manual / Conventional
Semi-automated
Fully-automated / Robotic
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
By Product Type
Equipment Microcentrifuges
Ultracentrifuges
Multipurpose/General-purpose
Accessories Tubes & Bottles
Rotors (fixed-angle, swinging-bucket)
Buckets/Plates/Consumables
By Model Type
Benchtop
Floor-standing
By Intended Use
Clinical
Pre-clinical/Research
General Purpose
By Application
Microbiology
Cellomics
Proteomics
Genomics
Diagnostics
By End-user
Hospitals & Diagnostic Labs
Academic & Research Institutes
Biotech & Pharma Companies
Contract Testing / CROs
By Automation Level
Manual / Conventional
Semi-automated
Fully-automated / Robotic
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current value of the laboratory centrifuge market?

The market is valued at USD 1.71 billion in 2025 and is forecast to reach USD 2.27 billion by 2030.

Which region is growing the fastest in the laboratory centrifuge market?

Asia-Pacific records the highest 7.76% CAGR to 2030 thanks to large-scale healthcare investments in China and India.

Why are accessories growing quicker than equipment?

Tubes, rotors, and seals are consumables that need regular replacement, pushing accessories to a 7.12% CAGR while equipment fleets last many years.

How is automation influencing centrifuge purchases?

Fully automated systems are expanding at 7.26% CAGR as laboratories address staff shortages and demand reproducible results with minimal manual handling.

Which application segment offers the best growth opportunity?

Cellomics leads with a 7.37% CAGR, driven by single-cell analysis and cell-therapy workflows that require gentle yet precise centrifugation.

Page last updated on: June 18, 2025

Global Laboratory Centrifuge Market Report Snapshots